Western Blot: 2-6 μg/mL. Immunohistochemistry: 5-20 μg/mL. Human spleen tissue can be used as a positive control. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freezing and thawing.
Storage
-20 °C/-80 °C
Storage Comment
Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
Target
BCMA (TNFRSF17)
(Tumor Necrosis Factor Receptor Superfamily, Member 17 (TNFRSF17))
Alternative Name
CD269 / BCMA
Background
BCMA is a recently identified receptor for BAFF. It binds BAFF and April. BAFF and its receptors induce B cell development and survival, activate NF-κB and c-Jun N-terminal kinase, and are involved in B cell associated autoimmune diseases.Synonyms: B-cell maturation protein, BCM, TNFRSF17, Tumor necrosis factor receptor superfamily member 17